Cargando…
Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
BACKGROUND: Oxidative stress and antioxidants have been implicated in many diseases including prostate cancer and benign prostatic hyperplasia (BPH). Lipid peroxidation contributes to oxidative stress. However, new and emerging antioxidants such as paraoxonase 1 (PON1) and arylesterase (ARE) associa...
Autores principales: | Asare, George Awuku, Andam, Sabina Ekua, Asare-Anane, Henry, Ammanquah, Seth, Anang-Quartey, Yvonne, Afriyie, Daniel K., Musah, Iddis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857163/ https://www.ncbi.nlm.nih.gov/pubmed/29556488 http://dx.doi.org/10.1016/j.prnil.2017.04.002 |
Ejemplares similares
-
Calcium - Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug – Croton membranaceus Müll.Arg
por: Asare, George Awuku, et al.
Publicado: (2017) -
Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
por: Erdem, Fazile Hatipoglu, et al.
Publicado: (2010) -
Paraoxonase and Arylesterase Activities in Dipper and Non-Dipper Prehypertensive Subjects
por: Yuksel, Murat, et al.
Publicado: (2015) -
Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023) -
Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
por: Schilcher, Irene, et al.
Publicado: (2021)